Evidence map›Paper›PMID 42820202›Full record

ArticleJournal of community medicine & public health2026

Personal and Family Perspectives Regarding Neurodegenerative Disorder Risk.

Daniel J Levendowski, Alyssa A Gamaldo, Simon Jg Lewis, Christine M Walsh, Chris Berka, Luigi Ferini-Strambi, Bradley F Boeve, Thomas C Neylan, Erik K St Louis, Charlene E Gamaldo

Abstract read
In one paragraph

Article in Journal of community medicine & public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel J LevendowskiAdvanced Brain Monitoring, Inc. Carlsbad, CA, USA.
Alyssa A GamaldoDepartment of Psychology, Clemson University, Clemson, SC, USA.
Simon Jg LewisParkinson's Disease Research Clinic, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
Christine M WalshFein Memory and Aging Center, University of California, San Francisco, CA, USA.
Chris BerkaAdvanced Brain Monitoring, Inc. Carlsbad, CA, USA.
Luigi Ferini-StrambiDepartment of Clinical Neurosciences, Universita Vita-Salute San Raffaele, Milan, Italy.
Bradley F BoeveDepartments of Neurology and Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Thomas C NeylanUCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
Erik K St LouisMayo Sleep Behavior and Neurophysiology Research Laboratory, Mayo Center for Sleep Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Departments of Neurology and Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Charlene E GamaldoDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)R44AG050326 · NIA · ADVANCED BRAIN MONITORING, INC. · PI BERKA, CHRIS · 2016 to 2024
$4.4M
Characterizing Alzheimer's Disease with INSPECDS: Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia SubtypesR44AG054256 · NIA · ADVANCED BRAIN MONITORING, INC. · PI BERKA, CHRIS · 2017 to 2018
$1.1M
NIA NIH HHS R44 AG050326NIA NIH HHS R44 AG054256
6 · The paper itself

Abstract

Background: It remains unclear how awareness-of and planning-for eventual neurodegenerative disorder (NDD) diagnosis and care is influenced by age, gender, and culture across worldwide societies. Methods: 100 participants from eight countries were surveyed targeting 1) opinions about how knowledge of being at risk for an NDD might impact quality-of-life, and 2) how knowing the NDD risk of a parent might impact the participant. Results: Participants showed strong agreement in their feelings and interest in knowing the NDD risk for both their parents and themselves, but age, gender, and country differences were observed. Openness to assessment of NDD risk for oneself was influenced by age, interest in investigating NDD mitigation strategies were greater in women, willingness to pay out-of-pocket to establish NDD risk differed across countries, and wanting to know a parent's NDD risk was subdued in Germany and Japan. Despite potential anxiety associated with NDD risk disclosure, benefits toward future planning were the primary driver in participants interested in knowing the risk of NDD in themselves or their parents. Discussion: Societal communication strategies aimed at public health NDD informational and screening initiatives should be sensitive toward considering population characteristics of age, gender, and country of residence. Younger adults and especially women should be targeted with educational messaging about managing NDD risk.

Indexed as

DementiaHealthcare managementMild cognitive impairmentNeurodegenerative disorder riskProdromal disclosure

Identifiers

PMID42820202
PMCPMC13626707

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.